ÌÒÉ«ÊÓƵ

Researchers at ÌÒÉ«ÊÓƵ, led by Biochemistry Professor Robert Batey, have developed compositions and methods for temporal regulation of single guide RNAs (sgRNAs) that comprise a small molecule-binding aptamer in the sgRNA, which enables

Scientists have been studying cyanobacteria and its many potential applications for decades, from cutting CO2 emissions to creating a substitute for oil-based plastics, but there wasn’t a deep understanding of the full life cycle and metabolism of

When do cells decide to divide? For 40 years, the textbook answer has been that this decision occurs in the first phase of a cell’s existence – right after a mother cell divides to become daughter cells. But researchers at ÌÒÉ«ÊÓƵ have found that

In a study published today, a team at ÌÒÉ«ÊÓƵ took advantage of a new microscopic technique to follow the lives of individual bacteria as they grew and divided in complex colonies. 

ÌÒÉ«ÊÓƵ researchers have developed a new approach to designing more sustainable buildings with help from some of the tiniest contractors out there.

Researchers have discovered the structure of the FACT protein—a mysterious protein central to the functioning of DNA

Lab Venture Challenge awards $900,000 to promising bioscience, physical science and engineering ventures

Telomerase reverse transcriptase (TERT), an enzyme associated with nearly all malignant human cancers, is even more diverse and unconventional than previously realized according to new research by CU Biochem and BioFrontiers' Distinguished

ÌÒÉ«ÊÓƵ and Howard Hughes Medical Institute (HHMI) biochemists have revealed a key regulatory process in a gene-suppressing protein group that could hold future applications for drug discovery and clinical treatment of diseases, including cancer.

A new drug therapy for cancer treatment, spun out of research performed in a ÌÒÉ«ÊÓƵ biochemistry lab, may provide better results for patients with solid cancers and hematologic cancers, such as leukemia and lymphoma.